HE homepage

population level clinical insights

The FDA-led Sentinel Initiative is tapping Oracle’s life-sciences division, Cerner Enviza, to spearhead development of AI tools for rendering EHR-bound clinical notes as usable pointers for clinicians and researchers.

artificial intelligence robot evaluates healthcare data. Novo Nordisk announced a new collaboration with Valo Health, a healthcare technology company focused on using artificial intelligence (AI) technology to identify new drug treatments for cardiovascular disease (CVD).

The popular chat-based AI model was able to answer straightforward questions with considerable accuracy. However, it still has certain issues that need to be addressed. 

According to Sanofi, it has withdrawn and refiled its premerger notification and report form with the FTC to give the agency more time to review the deal.

These findings underscore the need for better implementation of shared decision-making (SDM) models, as well as more thorough counseling documentation, as low-dose CT (LDCT) lung screen coverage is dependent on these factors, experts suggested.

Cases of chlamydia, gonorrhea and syphilis all rose between 2020 and 2021, totaling more than 2.5 million reported cases, according to CDC surveillance data

VIDEO: American Society of Nuclear Cardiology (ASNC) President Mouaz Al-Mallah, MD, chair of cardiovascular PET and associate director of nuclear cardiology, Houston Methodist DeBakey Heart and Vascular Center, and ASNC President-elect Larry Phillips, MD, director of nuclear cardiology, NYU Langone, outline the new technologies available and why upgrading cardiac nuclear labs matters and what is the ROI. #ASNC

Some nuclear cardiology labs are still using SPECT systems that are 20-25 years old. Is it time to make an upgrade? 

cardiovascular risk infectious disease hospitalization

CMS is also proposing that rural emergency hospitals be designated graduate medical education training sites, enabling more medical students to train in those areas.

Around the web

The approval, made as part of a special FDA pilot program, took just 50 days.